MKI67 and cancer: Those tested tended to have an earlier cancer stage at diagnosis: a greater proportion of Ki-67-tested patients had Stage I cancer than those not tested (18.0% vs 9.1%) and a lower proportion had Stage III cancer (8.2% vs 15.2%).